|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1999-9-2
|
|
pubmed:abstractText |
PET with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) is used for quantifying glucose metabolism in brain and myocardium in vivo. We developed and validated a similar procedure for the quantification of the two initial steps of glucose metabolism in skeletal muscle in vivo.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
977-85
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10452314-Adult,
pubmed-meshheading:10452314-Blood Glucose,
pubmed-meshheading:10452314-Body Mass Index,
pubmed-meshheading:10452314-Data Interpretation, Statistical,
pubmed-meshheading:10452314-Diabetes Mellitus, Type 2,
pubmed-meshheading:10452314-Fluorodeoxyglucose F18,
pubmed-meshheading:10452314-Glucose,
pubmed-meshheading:10452314-Humans,
pubmed-meshheading:10452314-Insulin,
pubmed-meshheading:10452314-Linear Models,
pubmed-meshheading:10452314-Male,
pubmed-meshheading:10452314-Middle Aged,
pubmed-meshheading:10452314-Models, Biological,
pubmed-meshheading:10452314-Muscles,
pubmed-meshheading:10452314-Phosphorylation,
pubmed-meshheading:10452314-Radiopharmaceuticals,
pubmed-meshheading:10452314-Tomography, Emission-Computed
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Quantification of glucose transport and phosphorylation in human skeletal muscle using FDG PET.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Heinrich-Heine-University, Düsseldorf, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
